Insider trades
Peter Greenleaf, Director of Pelthos Therapeutics PTHS, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $16.7K. The latest trade was on 04/02.
Peter Greenleaf
Director
- Company
- Pelthos Therapeutics PTHS
- First filing
- 23/03/06
- Trades
- 21 trades
- Buys / sales
- 0 / 7
- 12-month net buying
- −$16.7K
- Last trade
- 04/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
PTHS | Open-market sale10b5-1 plan | 04/02 | 04/06 | 797 sh2 trades | $20.92avg. | $16,671.12 | −3.1% |
AUPH | Open-market sale | 25/03/03–25/03/04 | 25/03/04 | 360,540 sh2 trades | $7.96avg. | $2,871,124.24 | −16.8% |
| Open-market sale | 24/03/06 | 24/03/07 | 126,981 sh | $5.60 | $711,093.6 | −7.7% | |
| Open-market saleAmendment | 23/03/02 | 24/02/22 | 33,047 sh | $8.78 | $290,152.66 | −3.3% | |
| Open-market sale | 23/03/02 | 23/03/06 | 32,750 sh | $8.94 | $292,785 | −3.2% |
